Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

This study has been completed.

Study NCT00289640 Information provided by Bristol-Myers Squibb

First Received: February 9, 2006 Last Updated: January 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given